Triple-negative breast cancer:

Triple-negative breast cancer: Is a new treatment within reach?

A new study is looking into ways of devising more effective, targeted treatments for triple-negative breast cancer.
Researchers are currently investigating a potential new avenue for the treatment of triple-negative breast cancer, which is a particularly aggressive breast cancer subtype.
Triple-negative breast cancer is a type of breast cancer wherein the tumours do not express estrogen receptor, progesterone receptor, or the genes that promote the production of a protein called HER2, which plays a role in the growth of some cancer cells.
These receptors typically promote the growth of cancerous tumours, and most types of breast cancer test positive for one or more of these.
By contrast, triple-negative breast cancer, as its name suggests, tests negative for these receptors. This type of cancer is especially aggressive and does not respond to the usual breast cancer therapies.
Research suggests that triple-negative breast cancer mostly affects Hispanic and African-American women, and it accounts for 10 to 20 percent of invasive breast cancer diagnosis.
A new study from the University of Freiburg in Germany is testing potential new avenues for the treatment of this type of cancer.
Dr Jochen Maurer, from the Center for Translational Cell Research, and Dr Roland Schüle, from the Center for Clinical Research - both based at the University of Freiburg - led groundbreaking research around cancer stem-like cells, which promote tumour growth and resilience.
Their teams developed a novel inhibitor for the epigenetic regulator KDM4, which is an enzyme that regulates gene expression and is implicated in the development of triple-negative breast cancer.
They hope that this might be the first step in devising a better, more targeted treatment for this aggressive type of cancer. The study's findings were reported in the journal Cancer Research.
Promising results of novel inhibitor
Much research has been conducted in an effort to understand what scientists term "cancer stem-like cells," which are cells that are very similar to normal stem cells in the body yet which promote cancerous activity.
Cancer stem-like cells are very adaptable, and they are often able to resist to the most invasive cancer therapies, thereby leading to the formation of new tumours and metastasis.

Triple-negative breast cancer: What you need to know
What are the features of triple-negative breast cancer?

The researchers have now managed to isolate cancer stem-like cells from human breast cancer tumours. This allowed them to have a closer look at the mechanisms of these cells and how they promote cancerous growth.
Dr Maurer and his colleagues managed to develop an in vitro model of cancer stem-like cells that faithfully corresponded to the ones extracted from the original triple-negative breast cancer tumours.
The teams of Drs. Maurer and Schüle then collaborated in testing the effectiveness of various epigenetic inhibitors using their new cancer stem cell model.
Drs. Maurer and Schüle found that a newly developed inhibitor of the KDM4 enzyme exhibited promising effects in its action on cancer stem-like cells.
The researchers managed to stop several stem-like cell populations from proliferating, and, by using the KDM4 inhibitor, they also succeeded in determining the cells to modify their "stem" state, thus rendering them less prone to promoting cancer.
Additionally, the scientists tested the inhibitor on mice in which human breast cancer tumours had been grown. These experiments also yielded promising results, as the researchers were able to reduce the growth of the tumours in the animals.

If the scientists' further research continues to bring successful results, this will bode well for the future of triple-negative breast cancer treatment, which currently has poor long-term outcomes. 

Comments

Post a Comment

Popular posts from this blog

Breast cancer charities: How to make an impact

Breast cancer charities: How to make an impact With thousands of charities competing for donations, it can be difficult to know where a financial gift to a good cause will make the biggest impact. This article outlines the top  breast cancer  charities in the United States and their specific contributions to the cause, plus other factors to keep in mind before donating. The history of the pink ribbon The pink ribbon is a symbol of breast cancer and is often sold to raise money for breast cancer charities. Breast cancer activist and survivor Charlotte Hayley inspired the design of the pink ribbon, which is still in use today. Hayley initially handed out peach-coloured looped ribbons that she made herself with a card stating: "The National Cancer Institute's annual budget is $1.8 billion, only 5 percent goes for  cancer  prevention. Help us wake up our legislators and America by wearing this ribbon." In 1991, the Susan G. Komen Breast Cancer Foundati...
Read more

Lung cancer and cough: What is the connection?

Image
Lung cancer and cough: What is the connection? Everyone has experienced a nagging cough after a cold or needed to cough while in a quiet room. Despite these problems, coughing actually serves a very valuable and useful purpose. Coughing is a protective action, helping the lungs clear out potential germs or harmful objects.  Sometimes, however, that cough is not linked to a cold or infection and can linger for weeks to months at a time. This may lead people to wonder or worry that their cough is a sign of something more serious, such as  lung cancer . This article takes a look at the connection between coughing and lung cancer, including when someone should see a doctor. Coughing and lung cancer A cough associated with lung cancer may be either dry or wet. Not every a cough signifies the presence of lung cancer. However, many people do complain of a chronic cough or a "cough that just won't go away" at the time of their diagnosis. If a cough is associate...
Read more

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management  Research shows a possible link between diabetes and cognitive decline, including increased risk for Alzheimer’s disease and vascular dementia. The scientific reason behind the link between diabetes and brain health is complex. Some scientists believe people with diabetes may also have insulin resistance or insulin deficiency that could damage brain cells enough to cause memory loss. Studies are underway to understand why 80 percent of people with Alzheimer’s disease also have some form of diabetes or disturbed glucose metabolism. However, so far, longitudinal research has not produced a consensus view regarding the link between blood glucose levels and cognitive impairment. Meanwhile, in South Florida, medical professionals are working with diabetic patients to minimize the risk of cognitive decline through a variety of methods that include lifestyle, medical and mental-...
Read more